Literature DB >> 25505316

Controlling NMDA receptor subunit composition using ectopic retention signals.

David Stroebel1, Stéphanie Carvalho1, Teddy Grand1, Shujia Zhu1, Pierre Paoletti2.   

Abstract

Ligand-gated ion channels (LGICs) mediate fast synaptic transmission in the CNS. Typically, these membrane proteins are multimeric complexes associating several homologous subunits around a central pore. Because of the large repertoire of subunits within each family, LGICs exist in vivo as multiple subtypes that differ in subunit composition and functional properties. Establishing the specific properties of individual receptor subtypes remains a major goal in the field of neuroscience and molecular pharmacology. However, isolating specific receptor subtype in recombinant systems can be problematic because of the mixture of receptor populations. This is the case for NMDA receptors (NMDARs), a large family of tetrameric glutamate-gated ion channels that play key roles in brain physiology and pathology. A significant fraction of native NMDARs are triheteromers composed of two GluN1 subunits and two different GluN2 subunits (GluN2A-D). We developed a method based on dual retention signals adapted from G-protein-coupled GABA-B receptors allowing exclusive cell surface expression of triheteromeric rat NMDARs while coexpressed diheteromeric receptors (which contain a single type of GluN2 subunit) are retained intracellularly. Using this approach, we determined the functional properties of GluN1/GluN2A/GluN2B triheteromers, one of the most abundant NMDAR subtypes in the adult forebrain, revealing their unique gating and pharmacological attributes. We envision applicability of the retention signal approach for the study of a variety of heteromeric glutamate-gated ion channel receptors with defined subunit composition.
Copyright © 2014 the authors 0270-6474/14/3416630-07$15.00/0.

Entities:  

Keywords:  NMDA receptor; glutamate; ligand-gated ion channel; membrane receptor; neurotransmitter receptor; pharmacology

Mesh:

Substances:

Year:  2014        PMID: 25505316      PMCID: PMC6608501          DOI: 10.1523/JNEUROSCI.2736-14.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  33 in total

1.  A trafficking checkpoint controls GABA(B) receptor heterodimerization.

Authors:  M Margeta-Mitrovic; Y N Jan; L Y Jan
Journal:  Neuron       Date:  2000-07       Impact factor: 17.173

2.  The C-terminal domains of the GABA(b) receptor subunits mediate intracellular trafficking but are not required for receptor signaling.

Authors:  A R Calver; M J Robbins; C Cosio; S Q Rice; A J Babbs; W D Hirst; I Boyfield; M D Wood; R B Russell; G W Price; A Couve; S J Moss; M N Pangalos
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

3.  C-terminal interaction is essential for surface trafficking but not for heteromeric assembly of GABA(b) receptors.

Authors:  A Pagano; G Rovelli; J Mosbacher; T Lohmann; B Duthey; D Stauffer; D Ristig; V Schuler; I Meigel; C Lampert; T Stein; L Prezeau; J Blahos; J Pin; W Froestl; R Kuhn; J Heid; K Kaupmann; B Bettler
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

4.  NMDA di-heteromeric receptor populations and associated proteins in rat hippocampus.

Authors:  Rana A Al-Hallaq; Thomas P Conrads; Timothy D Veenstra; Robert J Wenthold
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

5.  Modulation of triheteromeric NMDA receptors by N-terminal domain ligands.

Authors:  Christopher J Hatton; Pierre Paoletti
Journal:  Neuron       Date:  2005-04-21       Impact factor: 17.173

6.  The micromolar zinc-binding domain on the NMDA receptor subunit NR2B.

Authors:  Julie Rachline; Florent Perin-Dureau; Anne Le Goff; Jacques Neyton; Pierre Paoletti
Journal:  J Neurosci       Date:  2005-01-12       Impact factor: 6.167

7.  Structural rearrangements of NR1/NR2A NMDA receptors during allosteric inhibition.

Authors:  Marc Gielen; Anne Le Goff; David Stroebel; Jon W Johnson; Jacques Neyton; Pierre Paoletti
Journal:  Neuron       Date:  2008-01-10       Impact factor: 17.173

8.  Activation of a dimeric metabotropic glutamate receptor by intersubunit rearrangement.

Authors:  Carsten Brock; Nadia Oueslati; Stéphan Soler; Laure Boudier; Philippe Rondard; Jean-Philippe Pin
Journal:  J Biol Chem       Date:  2007-09-13       Impact factor: 5.157

9.  Intracellular domains of NR2 alter calcium-dependent inactivation of N-methyl-D-aspartate receptors.

Authors:  Bryce Vissel; Johannes J Krupp; Stephen F Heinemann; Gary L Westbrook
Journal:  Mol Pharmacol       Date:  2002-03       Impact factor: 4.436

10.  Evolution of NMDA receptor cytoplasmic interaction domains: implications for organisation of synaptic signalling complexes.

Authors:  Tomás J Ryan; Richard D Emes; Seth Gn Grant; Noboru H Komiyama
Journal:  BMC Neurosci       Date:  2008-01-15       Impact factor: 3.288

View more
  33 in total

1.  Pharmacology of triheteromeric N-Methyl-D-Aspartate Receptors.

Authors:  John Cheriyan; Rashna D Balsara; Kasper B Hansen; Francis J Castellino
Journal:  Neurosci Lett       Date:  2016-02-23       Impact factor: 3.046

2.  Properties of Individual Hippocampal Synapses Influencing NMDA-Receptor Activation by Spontaneous Neurotransmission.

Authors:  Sarah R Metzbower; Yuyoung Joo; David R Benavides; Thomas A Blanpied
Journal:  eNeuro       Date:  2019-05-29

Review 3.  Emerging roles of GluN3-containing NMDA receptors in the CNS.

Authors:  Isabel Pérez-Otaño; Rylan S Larsen; John F Wesseling
Journal:  Nat Rev Neurosci       Date:  2016-08-25       Impact factor: 34.870

4.  Activity-dependent control of NMDA receptor subunit composition at hippocampal mossy fibre synapses.

Authors:  Mario Carta; Bettadapura N Srikumar; Adam Gorlewicz; Nelson Rebola; Christophe Mulle
Journal:  J Physiol       Date:  2018-01-30       Impact factor: 5.182

5.  The Bioactive Protein-Ligand Conformation of GluN2C-Selective Positive Allosteric Modulators Bound to the NMDA Receptor.

Authors:  Thomas M Kaiser; Steven A Kell; Hirofumi Kusumoto; Gil Shaulsky; Subhrajit Bhattacharya; Matthew P Epplin; Katie L Strong; Eric J Miller; Bryan D Cox; David S Menaldino; Dennis C Liotta; Stephen F Traynelis; Pieter B Burger
Journal:  Mol Pharmacol       Date:  2017-12-14       Impact factor: 4.436

6.  Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization.

Authors:  Nathan G Glasgow; Nadezhda V Povysheva; Andrea M Azofeifa; Jon W Johnson
Journal:  J Neurosci       Date:  2017-09-06       Impact factor: 6.167

Review 7.  Dissecting diverse functions of NMDA receptors by structural biology.

Authors:  Jue Xiang Wang; Hiro Furukawa
Journal:  Curr Opin Struct Biol       Date:  2019-01-28       Impact factor: 6.809

8.  Functional and pharmacological properties of triheteromeric GluN1/2B/2D NMDA receptors.

Authors:  Feng Yi; Subhrajit Bhattacharya; Charles M Thompson; Stephen F Traynelis; Kasper B Hansen
Journal:  J Physiol       Date:  2019-11-02       Impact factor: 5.182

9.  Modulating synaptic NMDA receptors.

Authors:  Kenneth R Tovar; Gary L Westbrook
Journal:  Neuropharmacology       Date:  2016-08-23       Impact factor: 5.250

10.  Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors.

Authors:  Feng Yi; Tung-Chung Mou; Katherine N Dorsett; Robert A Volkmann; Frank S Menniti; Stephen R Sprang; Kasper B Hansen
Journal:  Neuron       Date:  2016-09-08       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.